JP2025517672A5 - - Google Patents
Info
- Publication number
- JP2025517672A5 JP2025517672A5 JP2024566410A JP2024566410A JP2025517672A5 JP 2025517672 A5 JP2025517672 A5 JP 2025517672A5 JP 2024566410 A JP2024566410 A JP 2024566410A JP 2024566410 A JP2024566410 A JP 2024566410A JP 2025517672 A5 JP2025517672 A5 JP 2025517672A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- chemical formula
- group
- formula
- glp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22172545 | 2022-05-10 | ||
| EP22172545.0 | 2022-05-10 | ||
| PCT/EP2023/062208 WO2023217744A1 (en) | 2022-05-10 | 2023-05-09 | Prodrugs of glp-1 polypeptide and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517672A JP2025517672A (ja) | 2025-06-10 |
| JP2025517672A5 true JP2025517672A5 (cg-RX-API-DMAC7.html) | 2026-05-01 |
Family
ID=81940650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024566410A Withdrawn JP2025517672A (ja) | 2022-05-10 | 2023-05-09 | プロドラッグおよびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250304645A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4522220A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025517672A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119173275A (cg-RX-API-DMAC7.html) |
| AR (1) | AR129270A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202346324A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023217744A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120659805A (zh) * | 2023-10-31 | 2025-09-16 | 深圳信立泰药业股份有限公司 | Glp-1化合物及其制备方法与应用 |
| WO2026052063A1 (en) * | 2024-09-06 | 2026-03-12 | Suzhou Spring-Sea Bio-Pharmaceuticals Co. Ltd. | Glp-1 polypeptide prodrugs and uses thereof |
| WO2026139053A1 (zh) * | 2024-12-27 | 2026-07-02 | 深圳信立泰药业股份有限公司 | 一种包含glp-1化合物的药物组合物及其制备方法与应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7238671B2 (en) * | 2001-10-18 | 2007-07-03 | Bristol-Myers Squibb Company | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| TWI362392B (en) | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| JP2012512898A (ja) | 2008-12-19 | 2012-06-07 | インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション | ジペプチド結合薬用剤 |
| EP2376097A4 (en) | 2008-12-19 | 2012-10-03 | Univ Indiana Res & Tech Corp | PEPTIDE PRODRUGS OF AMIDE-BASED GLUCAGON SUPERFAMILY |
| US20110306551A1 (en) | 2009-02-19 | 2011-12-15 | Novo Nordisk A/S | Modification of Factor VIII |
| US20120329711A1 (en) | 2009-12-16 | 2012-12-27 | Nordisk A/S | Glp-1 receptor agonist compounds with a modified n-terminus |
| US9062094B2 (en) | 2010-01-22 | 2015-06-23 | Ascendis Pharma As | Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
| US8778872B2 (en) | 2010-06-24 | 2014-07-15 | Indiana University Research And Technology Corporation | Amide based glucagon superfamily peptide prodrugs |
| JP6231386B2 (ja) | 2010-11-09 | 2017-11-15 | ノヴォ ノルディスク アー/エス | リンカーを有する二重アシル化されたglp−1誘導体 |
| ES2810153T3 (es) | 2012-03-01 | 2021-03-08 | Novo Nordisk As | Profármacos de GLP-1 |
| US20160058881A1 (en) | 2013-03-15 | 2016-03-03 | Indiana University Research And Technology Corporation | Prodrugs with prolonged action |
| EP3197912B1 (en) | 2014-09-24 | 2023-01-04 | Indiana University Research & Technology Corporation | Lipidated amide-based insulin prodrugs |
| AR114353A1 (es) | 2018-02-02 | 2020-08-26 | Novo Nordisk As | Composiciones sólidas que comprenden un agonista del glp-1 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico |
| TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
-
2023
- 2023-05-09 US US18/864,190 patent/US20250304645A1/en active Pending
- 2023-05-09 AR ARP230101137A patent/AR129270A1/es unknown
- 2023-05-09 WO PCT/EP2023/062208 patent/WO2023217744A1/en not_active Ceased
- 2023-05-09 CN CN202380039160.4A patent/CN119173275A/zh active Pending
- 2023-05-09 JP JP2024566410A patent/JP2025517672A/ja not_active Withdrawn
- 2023-05-09 TW TW112117140A patent/TW202346324A/zh unknown
- 2023-05-09 EP EP23726891.7A patent/EP4522220A1/en not_active Withdrawn